Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
FDA
Biotech
Clinical Trials
Car-T Therapy
Obesity
Parkinson's Disease
Oncology
Immunology
Breast Cancer
Gene Therapy
Multiple Myeloma
Takeda
Artificial Intelligence
Mergers and Acquisitions
Biotechnology
Alzheimer's Disease
TYK2
Biotech Industry
Rare Disease
Abivax

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes427Foundeda year ago
Number of ListenersCategories
ScienceLife Sciences

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

Co-Founder & CEO Natalie Mount discusses the raise, and explains why she believes gamma delta T-cell engagers have advantages over CD3s. After presenting preclinical data at the recent AACR annual meeting, the lead EGFR program is preparing to go int... more

Philip Astley-Starke describes the timeline of development of this oncolytic immunotherapy, his impression of FDA's review process and decisions around it, and the status of where the treatment stands today.

CSO Robert Allen describes Invivyd's approach and why antibodies can be a good approach, especially as it relates to being resistant to viral evolution. He walks us through the science and some potential use cases.

Co-Founder & CEO Michel Maharbiz describes the idea behind this brain-computer interface (BCI), which is not yet in human trials. While cautioning that much work and learning lies ahead, he sees the possibility that such a system could also improve a... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Natalie Mount
CEO and co-founder of Cytospire Therapeutics
Cytospire Therapeutics
Episode: London based Cytospire Therapeutics has announced an $83M series A financing to develop first-in-class pan-gamma delta T-cell engagers - the lead program is an EGFR targeting solid tumors
Philip Astley-Starke
Chairman and co-founder of Replimune
Replimune
Episode: Replimune's Chairman discusses FDA's polarizing decision to not approve the company's melanoma treatment after a new review. He says they have filed a FOIA request to learn more about FDA's process
Michel Maharbiz
Co-founder of Epia Neuro
Epia Neuro
Episode: Bay Area based Epia Neuro exited stealth earlier this month with the goal of developing a device implanted in the skull that could act as an interface to a glove to helps stroke survivors regain grip
Peter Hotez
Professor of pediatrics and molecular virology and microbiology at Baylor College of Medicine; co-director of the Center for Vaccine Development at Texas Children's Hospital
Baylor College of Medicine
Episode: Peter Hotez discusses tropical disease, the importance of science communication, career advice for young scientists, and more
Adam May
Physician and investor
Episode: Physican and Biotech Investor Adam May reacts to this morning's 52 week Rezpeg data in alopecia from Nektar
Serge Saxonov
CEO of 10x Genomics
10x Genomics
Episode: 10x Genomics today is announcing Atera, its new in situ spatial transcriptomics platform
Rajesh Kumar
Head of health care at HSBC
HSBC
Episode: Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated
Tiago Fauci
Analyst at Raymond James covering biotech investments
Raymond James
Episode: Raymond James Biotech Innovation Symposium: Biotech analyst Tiago Fauth shares his read on the mood of investors and discusses companies he covers
Ram Aiyer
CEO of Korro Bio
Korro Bio
Episode: Raymond James Biotech Innovation Symposium: Korro Bio CEO Ram Aiyer discussed how the company has chosen new RNA editing programs to move forward with this year

Host

Brad
Host of the BiotechTV segments; coverage and interviews

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Raymond James Biotech Innovation Symposium: Raymond James analyst Chris Raymond shares his take on biotech and companies he covers
Q: What is the outlook for Monopar and its Wilson disease asset in the regulatory calendar, and why is this significant for the company?
Monopar's upcoming regulatory filing for Wilson disease aims to validate its asset and potentially unlock partnerships or buyouts, given the strategic importance of niche, regulatory-cleared therapies in smaller biotech markets.
Raymond James Biotech Innovation Symposium: Raymond James analyst Chris Raymond shares his take on biotech and companies he covers
Q: How does Siona's NBD-1 stabilization strategy potentially change the CF landscape, and what would be required to demonstrate real proof of concept?
Siona is pursuing NBD-1 stabilization to address an undruggable target, with expectations for mid-year proof of concept data. If stabilization plus Trikafta co-therapy shows meaningful reductions in sweat chloride, it could open the door to a proprietary combo that challenges Vertex.
Raymond James Biotech Innovation Symposium: Raymond James analyst Chris Raymond shares his take on biotech and companies he covers
Q: What makes Tyra and its FGFR3 asset particularly compelling for the near term, and what are the expected catalysts this summer?
Tyra's FGFR3 program is approaching a pivotal three-month CR readout in bladder cancer, with a comparison to a toxic dataset from Ertifitinib suggesting a potential favorable safety profile. The market is watching for a three-month complete response rate that could set up a strong longer-term readout and a possible approvable endpoint.
Harbinger Health is announcing its emphasis on a new category of cancer screening tests today, RESOLVE, that are meant to be used upon the suspicion of cancer symptoms to speed diagnosis and treatment
Q: When can we expect commercialization and go-to-market activities?
The first Resolve product is expected later this year, with go-to-market efforts beginning in the same year, and potential revenue in 2026 as indicated.
Harbinger Health is announcing its emphasis on a new category of cancer screening tests today, RESOLVE, that are meant to be used upon the suspicion of cancer symptoms to speed diagnosis and treatment
Q: Is this something the FDA supports, and how will it be brought to market?
The team has engaged with the FDA throughout the study design phase to gain guidance, and the product will launch as a laboratory-developed test (LDT) initially, enabling faster market entry.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

A fast-moving, industry-focused show that reports on biotech hubs worldwide through on-the-ground coverage, interviews with company leaders, investors, and scientists, and regular analysis of clinical data, deals, and regulatory timing. Recent episodes emphasize breakthroughs in spatial biology, antibody and RNA-based therapies, GPCR drug discovery, and obesity and nephrology programs, paired with investor mood and market dynamics from major biotech conferences. The program stands out for pairing frontline company updates with context on clinical milestones, regulatory timelines, and funding activity, making it valuable for listeners who need timely, actionable biotech intel and expert perspectives to inform sponsorships, pitches, or portfo... more

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. Biotech Hangout
2. BioCentury This Week
3. The Long Run with Luke Timmerman
4. The Readout Loud
5. BioVenture VoiCes with Chris Garabedian

How many episodes of BiotechTV are there?

BiotechTV launched a year ago and published 427 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Natalie Mount
2. Philip Astley-Starke
3. Michel Maharbiz
4. Peter Hotez
5. Adam May
6. Serge Saxonov
7. Rajesh Kumar
8. Tiago Fauci

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days